Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
出版年份 2018 全文链接
标题
Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
作者
关键词
-
出版物
Future Oncology
Volume 14, Issue 10, Pages 919-926
出版商
Future Medicine Ltd
发表日期
2018-03-12
DOI
10.2217/fon-2017-0499
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Are TKIs favourable for the elderly with non-small-cell lung cancer?
- (2016) Sabrina Rossi et al. Oncotarget
- A Whole-Body Physiologically Based Pharmacokinetic Model of Gefitinib in Mice and Scale-Up to Humans
- (2015) Youwei Bi et al. AAPS Journal
- Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer
- (2015) O. Arrieta et al. ONCOLOGIST
- Influence of cancer cachexia on drug liver metabolism and renal elimination in rats
- (2015) Katja Cvan Trobec et al. Journal of Cachexia Sarcopenia and Muscle
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
- (2014) Madoka Kimura et al. SUPPORTIVE CARE IN CANCER
- Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
- (2013) O Huillard et al. BRITISH JOURNAL OF CANCER
- Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study
- (2013) Marie-Hélène Massicotte et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer
- (2013) Sami Antoun et al. Current Opinion in Supportive and Palliative Care
- Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
- (2012) Olivier Mir et al. PLoS One
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
- (2010) A. J. Cruz-Jentoft et al. AGE AND AGEING
- Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
- (2010) Vickie E Baracos et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis
- (2010) Luis Paz-Ares et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
- (2010) Sami Antoun et al. JOURNAL OF CLINICAL ONCOLOGY
- Cachexia as a major underestimated and unmet medical need: facts and numbers
- (2010) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now